Parexel International Corporation
#101C
Newton, MA 02466
Share:
Data Capture Software promotes clinical trial process efficiency.
Electronic Data Capture (EDC) solution DataLabsÃ-® v5.0 enables clinical trial sponsors to manage clinical development process from study design to collection and reporting of study data. Interoperability with other systems in Perceptive eClinical Suite provides real-time data interchange and promotes effective decision making. Offered as SaaS application, program incorporates reporting...
Read More »PAREXEL Introduces New Technology Platform to Bring Greater Efficiency to Late Phase Studies
BOSTON, -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that it has introduced a new web-based technology platform for late phase clinical research to meet the expanding regulatory and commercialization needs of the biopharmaceutical industry. The platform brings greater cost effectiveness to conducting large-scale studies...
Read More »PAREXEL Expands Patient Recruitment Services with Technology to Enhance Recruitment Strategy and Execution
BOSTON, June 12 / -- PAREXEL International Corporation, a leading global bio/pharmaceutical services organization, is making patient recruitment and retention strategy, planning and execution more effective for clinical trial sponsors with an expanded offering that includes an expert recruitment team supported by new technology that it believes substantially improves patient recruitment...
Read More »Software streamlines clinical trial processes.
Interactive Web Response System v2.0 provides web interface for data capture, patient randomization, and management of study drug inventory for clinical trials. It allows study teams to access real-time web reporting for all aspect of clinical trials tracking. Interactive features include snapshots of project status as well as detailed study metrics, enabling trial monitors to follow progress of...
Read More »PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership in Pharmacovigilance Services
Will add global scale to meet growing demand for safety services BOSTON –Ã- PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India ( QSI ), a leading provider of specialized pharmacovigilance services, based...
Read More »Data Capture Software promotes clinical trial process efficiency.
Electronic Data Capture (EDC) solution DataLabsÃ-® v5.0 enables clinical trial sponsors to manage clinical development process from study design to collection and reporting of study data. Interoperability with other systems in Perceptive eClinical Suite provides real-time data interchange and promotes effective decision making. Offered as SaaS application, program incorporates reporting...
Read More »PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting
BOSTON, March 7, 2011 - Through various presentations to be delivered at the Drug Information Association (DIA) 23rd Annual EuroMeeting, being held March 28-30, 2011 in Geneva, Switzerland, experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will address advanced approaches to help the biopharmaceutical industry meet demands of a...
Read More »PAREXEL International to Present at J.P. Morgan Healthcare Conference
BOSTON, Jan. 4, 2011 - PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the J.P. Morgan Healthcare Conference in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at 8:30 a.m. PT on Thursday, January 13, 2011. A live webcast of this presentation will be available through the Investors section...
Read More »PAREXEL International to Participate in Lazard Capital Medical Technology / Life Science Tools Day and Deutsche Bank MedTools Investor Summit
BOSTON, Nov. 29, 2010 - PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be participating in the Lazard Capital Medical Technology / Life Science Tools Day in Denver, CO on Thursday, December 2, 2010. PAREXEL will also be participating in the Deutsche Bank MedTools Investor Summit in Boston, MA on Tuesday, December 7, 2010. About PAREXEL International PAREXEL International...
Read More »PAREXEL Expert to Lead Track on Global Clinical Outsourcing at Partnerships in Clinical Trials Europe Conference
BOSTON, Nov. 8, 2010 - Thought leaders from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will address best practices in strategic partnering and requirements for successful global clinical development during the 9th Annual Partnerships in Clinical Trials Europe Conference. PAREXEL is a sponsor of the conference, which will be held...
Read More »PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum
BOSTON, Oct. 25 - PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Oppenheimer Healthcare Conference in New York. James Winschel, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL at 2:45 p.m. E.T. on Wednesday, November 3, 2010. A live webcast of this presentation will be available through the Investors section...
Read More »PAREXEL International to Present at Robert W. Baird Healthcare Conference
BOSTON, Sept. 7 - PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Robert W. Baird Healthcare Conference in New York, New York. James Winschel, Senior Vice President & Chief Financial Officer will be making a presentation on PAREXEL at 10:30 a.m. ET on Tuesday, September 14, 2010. A live webcast of this presentation will be available through the...
Read More »PAREXEL Introduces Temperature Recording Solution for Study Drug Transportation, Bringing More Efficiency to Clinical Supply Chain
BOSTON, Aug. 19 - PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today announced that it has introduced an integrated temperature recording solution for study drug transportation as part of its expanded Clinical Logistics Services. PAREXEL's temperature control process saves 24 to 48 hours of time over traditional cold chain methods in...
Read More »PAREXEL Introduces New Technology Platform to Bring Greater Efficiency to Late Phase Studies
BOSTON, -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that it has introduced a new web-based technology platform for late phase clinical research to meet the expanding regulatory and commercialization needs of the biopharmaceutical industry. The platform brings greater cost effectiveness to conducting large-scale studies...
Read More »